HomeHLS • TSE
add
HLS Therapeutics Inc
Previous close
$5.00
Day range
$4.87 - $5.00
Year range
$3.25 - $5.77
Market cap
156.06M CAD
Avg Volume
11.23K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 13.51M | -4.08% |
Operating expense | 11.08M | -9.98% |
Net income | -3.92M | 19.12% |
Net profit margin | -29.00 | 15.67% |
Earnings per share | -0.12 | — |
EBITDA | 4.14M | 14.44% |
Effective tax rate | 0.43% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.78M | -38.55% |
Total assets | 140.23M | -18.35% |
Total liabilities | 78.49M | -15.07% |
Total equity | 61.74M | — |
Shares outstanding | 31.27M | — |
Price to book | 2.54 | — |
Return on assets | -2.37% | — |
Return on capital | -2.89% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.92M | 19.12% |
Cash from operations | 2.48M | 64.96% |
Cash from investing | -279.00K | 81.40% |
Cash from financing | -3.44M | 77.19% |
Net change in cash | -1.38M | 90.82% |
Free cash flow | 2.06M | 9.64% |
About
Founded
2014
Website
Employees
85
